rs61162043
From SNPedia
Orientation | plus |
Stabilized | plus |
Make rs61162043(A;A) |
Make rs61162043(A;G) |
Make rs61162043(G;G) |
Reference | GRCh38 38.1/141 |
Chromosome | 16 |
Position | 31102913 |
is a | snp |
is | mentioned by |
dbSNP | rs61162043 |
dbSNP (classic) | rs61162043 |
ClinGen | rs61162043 |
ebi | rs61162043 |
HLI | rs61162043 |
Exac | rs61162043 |
Gnomad | rs61162043 |
Varsome | rs61162043 |
LitVar | rs61162043 |
Map | rs61162043 |
PheGenI | rs61162043 |
Biobank | rs61162043 |
1000 genomes | rs61162043 |
hgdp | rs61162043 |
ensembl | rs61162043 |
geneview | rs61162043 |
scholar | rs61162043 |
rs61162043 | |
pharmgkb | rs61162043 |
gwascentral | rs61162043 |
openSNP | rs61162043 |
23andMe | rs61162043 |
SNPshot | rs61162043 |
SNPdbe | rs61162043 |
MSV3d | rs61162043 |
GWAS Ctlg | rs61162043 |
GMAF | 0.4325 |
Max Magnitude | 0 |
[PMID 21270790] associations with higher warfarin dose, namely, VKORC1-8191 (rs61162043, P = 0.0041) and 18786 in CYP2C9 (rs7089580, P = 0.035) independent of the previous associations with these genes
[PMID 22158446] Association of the GGCX (CAA)16/17 repeat polymorphism with higher warfarin dose requirements in African Americans.